Bank of New York Mellon Corp Has $67.82 Million Stake in Avantor, Inc. $AVTR

Bank of New York Mellon Corp grew its stake in shares of Avantor, Inc. (NYSE:AVTR) by 5.4% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 5,038,544 shares of the company’s stock after purchasing an additional 258,268 shares during the period. Bank of New York Mellon Corp owned about 0.74% of Avantor worth $67,819,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Envestnet Asset Management Inc. grew its holdings in Avantor by 6.9% during the first quarter. Envestnet Asset Management Inc. now owns 682,325 shares of the company’s stock worth $11,060,000 after buying an additional 44,073 shares in the last quarter. State of Michigan Retirement System boosted its holdings in Avantor by 1.1% during the 1st quarter. State of Michigan Retirement System now owns 163,000 shares of the company’s stock worth $2,642,000 after acquiring an additional 1,800 shares during the last quarter. Xponance Inc. boosted its holdings in Avantor by 0.9% during the 1st quarter. Xponance Inc. now owns 114,422 shares of the company’s stock worth $1,855,000 after acquiring an additional 966 shares during the last quarter. Diversify Wealth Management LLC grew its stake in shares of Avantor by 18.6% in the 1st quarter. Diversify Wealth Management LLC now owns 48,724 shares of the company’s stock worth $790,000 after acquiring an additional 7,655 shares in the last quarter. Finally, Louisiana State Employees Retirement System raised its holdings in shares of Avantor by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 190,700 shares of the company’s stock valued at $3,091,000 after purchasing an additional 1,800 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Trading Up 1.8%

NYSE:AVTR opened at $11.53 on Monday. Avantor, Inc. has a 12 month low of $10.82 and a 12 month high of $23.32. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65. The firm’s 50 day moving average is $13.16 and its 200 day moving average is $13.11. The stock has a market capitalization of $7.86 billion, a PE ratio of -88.65, a price-to-earnings-growth ratio of 3.98 and a beta of 1.00.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.01). The firm had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.65 billion. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. Avantor’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same period last year, the company posted $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Sell-side analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Barclays restated an “equal weight” rating and set a $12.00 price target (down from $15.00) on shares of Avantor in a report on Thursday, October 30th. Royal Bank Of Canada cut their target price on Avantor from $20.00 to $17.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Evercore ISI reduced their target price on Avantor from $16.00 to $14.00 and set an “outperform” rating for the company in a report on Thursday, October 30th. Robert W. Baird lifted their price target on Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Finally, Raymond James Financial downgraded Avantor from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 4th. Four investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $14.42.

Insiders Place Their Bets

In other news, Director Gregory L. Summe acquired 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The stock was bought at an average price of $11.25 per share, with a total value of $1,125,000.00. Following the acquisition, the director owned 300,000 shares in the company, valued at $3,375,000. The trade was a 50.00% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.20% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.